Auristatin F-Delivering SNAP-Tag Based Recombinant Antibody-Drug Conjugate Targeting EpCAM Demonstrating Selective In vitro Killing of Cervical and Triple-Negative Breast Cancer Cell Lines
Journal of Pharmacy and Pharmacology Research · 2026 · 10 (01)
DOI: 10.26502/fjppr.0120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology Research, 2026. Verfasst von Ursula-Claire Andong-Koung-Edzidzi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
ConjugateTargeting EpCAM Demonstrating Selective In vitro Killing of Cervical and Triple-Negative Breast
Zitieren
APA
Andong-Koung-Edzidzi, U., Matshoba, T., Lang, D., Hunter, R., & Barth, S. (2026). Auristatin F-Delivering SNAP-Tag Based Recombinant Antibody-Drug Conjugate Targeting EpCAM Demonstrating Selective In vitro Killing of Cervical and Triple-Negative Breast Cancer Cell Lines. Journal of Pharmacy and Pharmacology Research, 10(01). https://doi.org/10.26502/fjppr.0120
Vancouver
Andong-Koung-Edzidzi U, Matshoba T, Lang D, Hunter R, Barth S. Auristatin F-Delivering SNAP-Tag Based Recombinant Antibody-Drug Conjugate Targeting EpCAM Demonstrating Selective In vitro Killing of Cervical and Triple-Negative Breast Cancer Cell Lines. Journal of Pharmacy and Pharmacology Research. 2026;10(01). doi:10.26502/fjppr.0120
BibTeX
@article{AndongKoungEdzidzi2026,
author = {Andong-Koung-Edzidzi, Ursula-Claire and Matshoba, Thabo and Lang, Dirk and Hunter, Roger and Barth, Stefan},
title = {Auristatin F-Delivering SNAP-Tag Based Recombinant Antibody-Drug Conjugate Targeting EpCAM Demonstrating Selective In vitro Killing of Cervical and Triple-Negative Breast Cancer Cell Lines},
journal = {Journal of Pharmacy and Pharmacology Research},
year = {2026},
volume = {10},
number = {01},
doi = {10.26502/fjppr.0120}
}
EUVIMED